CClinicalTrials.gg
CompletedNCT01228539MPTSDUpdated May 13, 2013

Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study

An interventional study of TARGET (Trauma Affect Regulation) and Prolonged Exposure in PTSD, Anger and Aggression, sponsored by UConn Health. Completed at 1 site in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-05-13.

Sponsored by UConn Health · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

The study will compare the efficacy of Trauma Affect Regulation: Guide for Education and Therapy (TARGET) vs. the best validated psychotherapy for adults with posttraumatic stress disorder (PTSD), Prolonged Exposure (PE). Male military personnel and veterans suffering with PTSD and problems with anger after returning from military service in Afghanistan (Operation Emerging Freedom, OEF) and/or Iraq (Operation Iraqi Freedom, OIF) will be participants. The goal is to determine if a present-centered psychotherapy that teaches skills for emotion regulation and does not require re-telling of traumatic memories is as efficacious as the trauma memory-focused PE psychotherapy.

Read the detailed description

The study is based on a theoretical and clinical model that involves a series of associated risks that are set in motion by exposure to military-related traumatic stressors in Iraq or Afghanistan. Trauma exposure places personnel at risk for PTSD, which in turn increases their risk of problems with anger and hostility, emotion dysregulation and experiential avoidance, and ultimately with alcohol abuse and aggression. The two types of treatments being compared, TARGET (Trauma Affect Regulation: Guide for Education and Therapy) and PE (Prolonged Exposure), are both designed to directly reduce PTSD severity by reducing emotion dysregulation (TARGET) and experiential avoidance (PE), and therefore are hypothesized to reduce the risk and severity of alcohol abuse and aggression- and thereby to reduce associated legal and societal costs.

02

Conditions studied

  • PTSD
  • Anger
  • Aggression

Browse trials for

Keywords

  • PTSD
  • Anger
  • Aggression
  • Military
03

In context

Aggression

361 studies on the registry are indexed under Aggression; 51 are open to participants now.

This study's enrollment of 31 is below the median of 60 across 293 interventional studies indexed under Aggression.

Browse Aggression studies →

Lead sponsor

UConn Health is the lead sponsor of 182 studies on the registry; 18 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • be a returning OEF/OIF military personnel or veteran
  • have experienced PTSD for the past month
  • have experienced anger and at least one act of aggression in the last month
  • be mentally able to provide a valid consent

Exclusion criteria

Exclusion Criteria:

  • currently be danger of suicide
  • currently abusing alcohol or other substances
  • been in an inpatient psychiatric or addiction treatment program in the past month
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    TARGET

    Affect regulation psychotherapy for PTSD

    Behavioral: TARGET (Trauma Affect Regulation)

  • Active comparator
    Prolonged Exposure

    Cognitive behavioral therapy for PTSD with trauma memory exposure

    Behavioral: Prolonged Exposure

Interventions

  • BehavioralTARGET (Trauma Affect Regulation)

    TARGET teaches a skill sequence for affect regulation and social/interpersonal information processing.

    Also known as: TARGET

  • BehavioralProlonged Exposure

    Cognitive behavior therapy with trauma memory exposure

06

What researchers measure

Primary outcomes

  1. Severity of PTSD symptoms

    Clinician Administered PTSD Scale Ordinal Scores Posttraumatic Cognitions Inventory Trauma Memory Questionnaire Interpretation of PTSD Symptoms Scale

    Time frame: Post-therapy

Secondary outcomes

  1. Anger/aggression problems

    State-Trait Anger Expression Inventory Brief Symptom Inventory

    Time frame: Post-therapy

  2. Emotion Regulation

    Negative Mood Regulation scale Difficulty with Emotion Regulation Scale Acceptance and Action Questionnaire

    Time frame: Post-therapy

07

Study locations

1 site
  • University of Connecticut Health Center
    Farmington, Connecticut 06030-1410, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01228539
Lead sponsor
UConn Health
Collaborators
University of Pennsylvania
Responsible party
Julian Ford (Professor, UConn Health) — Principal investigator
First posted
Oct 26, 2010
Start date
Jan 2010
Primary completion
Dec 2012
Completion
Dec 2012
Last update
May 13, 2013

Study contacts

Julian Ford, Ph.D.
principal investigator · UConn Health

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion